Determinants of Hepatitis-B Vaccine Uptake Among Antenatal Care Attendees at Primary Health Care Facilities in an Urban LGA of Nigeria
International Journal of Public Health and Pharmacology · 2026
DOI: 10.52589/ijphp-gcehir69 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Public Health and Pharmacology, 2026. Verfasst von A. I. und 5 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Despite the proven efficacy of the Hepatitis B vaccine (HBV) in preventing Hepatitis B disease and its adverse health outcomes for mother and child, the vaccination coverage among pregnant women remains alarmingly low in sub-Saharan countries, including Nigeria. This study assessed the Hepatitis B vaccine uptake and associated factors among pregnant women attending antenatal care at primary health care facilities in Obio/Akpor, Rivers State, Nigeria. A facility-based cross-sectional survey was conducted across eight primary healthcare facilities from August to September 2024 using an interviewer-administered questionnaire. Data were collected from 352 participants and analysed using proportion, chi-square, and binary logistic regression with statistical significance set at p ≤ 0.05 and a 95% confidence interval not including unity. The prevalence of HBV uptake is 24.1% (95% CI = 19.63 – 28.56). Women aged 29-36 years have the highest prevalence, 32% (95% CI = 27.33-36.66), while pregnant women aged 20-28 years have the lowest prevalence, 13.4% (95% CI = 9.84-16.95). Major reasons for not taking the vaccine include fear of side effects (24.4%), reluctance (18.7%), fear of injection (18.4%), vaccine inaccessibility (13%), and cost (11.6%). HBV uptake was significantly influenced by age, marital status, educational level, employment status, the influence of the partner’s decision, and gestational age. There is a low uptake of the HBV vaccine among pregnant women seeking care at the primary healthcare facilities in Obio/Akpor LGA, Rivers State, Nigeria. This can be mitigated through health education, training of primary health workers, and integration of free HBV into the antenatal care components.
Zitieren
APA
I., A., Wegbom, Z., Nwinee, A., S., & Ike-Wegbom (2026). Determinants of Hepatitis-B Vaccine Uptake Among Antenatal Care Attendees at Primary Health Care Facilities in an Urban LGA of Nigeria. International Journal of Public Health and Pharmacology. https://doi.org/10.52589/ijphp-gcehir69
Vancouver
I. A, Wegbom, Z., Nwinee, A. S, Ike-Wegbom. Determinants of Hepatitis-B Vaccine Uptake Among Antenatal Care Attendees at Primary Health Care Facilities in an Urban LGA of Nigeria. International Journal of Public Health and Pharmacology. 2026. doi:10.52589/ijphp-gcehir69
BibTeX
@article{I2026,
author = {I., A. and Wegbom and Z. and Nwinee and A., S. and Ike-Wegbom},
title = {Determinants of Hepatitis-B Vaccine Uptake Among Antenatal Care Attendees at Primary Health Care Facilities in an Urban LGA of Nigeria},
journal = {International Journal of Public Health and Pharmacology},
year = {2026},
doi = {10.52589/ijphp-gcehir69}
}
EUVIMED